Vaccines for preventing pneumococcal infection in adults (Q24242290)

https://api.crossref.org/works/10.1002%2F14651858.CD000422.PUB2

Prevention of Pneumococcal Infection by Immunization with Capsular Polysaccharides of Streptococcus pneumoniae: Current Status of Polyvalent Vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000422.PUB2

Effectiveness of the 23-valent polysaccharide vaccine against invasive pneumococcal disease in Navajo adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000422.PUB2

Pneumococcal infection and immunologic response to pneumococcal vaccine in chronic obstructive pulmonary disease. A pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000422.PUB2

Effectiveness of pneumococcal polysaccharide vaccine in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000422.PUB2

Immunisation with a polyvalent pneumococcal vaccine. Reduction of adult respiratory mortality in a New Guinea Highlands community

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000422.PUB2

A controlled evaluation of the protective efficacy of pneumococcal vaccine for patients at high risk of serious pneumococcal infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000422.PUB2

The protective efficacy of polyvalent pneumococcal polysaccharide vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000422.PUB2

Efficacy of pneumococcal vaccine in high-risk patients. Results of a Veterans Administration Cooperative Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000422.PUB2

Protective Efficacy of Pneumococcal Polysaccharide Vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000422.PUB2

Effectiveness of a 23-valent polysaccharide vaccine in preventing pneumonia and non-invasive pneumococcal infection in elderly people: a large-scale retrospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000422.PUB2

Maxwell Finland Lecture. Random gleanings from a life with the pneumococcus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000422.PUB2

Evaluation of effectiveness of the 23-valent pneumococcal capsular polysaccharide vaccine for HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000422.PUB2

Additive preventive effect of influenza and pneumococcal vaccines in elderly persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000422.PUB2

Pneumococcal disease among human immunodeficiency virus-infected persons: incidence, risk factors, and impact of vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000422.PUB2

Simultaneous immunisation with influenza vaccine and pneumococcal polysaccharide vaccine in patients with chronic respiratory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000422.PUB2

Inefficacy of pneumococcal vaccine in a high-risk population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000422.PUB2

Prevention of otitis media in children by pneumococcal vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000422.PUB2

PREVENTION OF PNEUMOCOCCAL PNEUMONIA BY IMMUNIZATION WITH SPECIFIC CAPSULAR POLYSACCHARIDES

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000422.PUB2

Effect of prior pneumococcal vaccination on clinical outcome of hospitalized adults with community-acquired pneumococcal pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000422.PUB2

Serum therapy revisited: animal models of infection and development of passive antibody therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000422.PUB2

The effectiveness of pneumococcal polysaccharide vaccines in adults: a systematic review of observational studies and comparison with results from randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000422.PUB2

Efficacy of pneumococcal polysaccharide vaccine in immunocompetent adults: a meta-analysis of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000422.PUB2

Pneumococcal vaccination in the United States and 20 other developed countries, 1981-1996.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000422.PUB2

The burden of pneumococcal disease among adults in developed and developing countries: what is and is not known

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000422.PUB2

Efficacy of pneumococcal vaccination in adults. A meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000422.PUB2

Injectable vaccines for preventing pneumococcal infection in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000422.PUB2

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000422.PUB2

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000422.PUB2

Mapping of the mouse actin capping protein beta subunit gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000422.PUB2

Strategies for the control of pneumococcal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000422.PUB2

Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000422.PUB2

Immunoglobulin GM and KM allotypes and vaccine immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000422.PUB2

Bacteraemia and antibiotic resistance of its pathogens reported in England and Wales between 1990 and 1998: trend analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000422.PUB2

Vaccines for preventing influenza in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000422.PUB2

The pneumococcus at the gates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000422.PUB2

Pneumococcal polysaccharide vaccine: a systematic review of clinical effectiveness in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000422.PUB2

Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000422.PUB2

Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in adults aged 65 years or older: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000422.PUB2

Impact of Pneumococcal Vaccination on Morbidity and Mortality of Geriatric Patients: A Case-Controlled Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000422.PUB2

Response to pneumococcal vaccine in chronic obstructive lung disease—The effect of ongoing, systemic steroid treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000422.PUB2

The Pneumococcal Vaccine After 15 Years of Use

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000422.PUB2

Statistical Methods for Examining Heterogeneity and Combining Results from Several Studies in Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000422.PUB2

The health and economic benefits associated with pneumococcal vaccination of elderly persons with chronic lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000422.PUB2

7 January 2021

Pneumonia in old age; active immunization against pneumonia with pneumonococcus polysaccharide; results of a six year study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000422.PUB2

7 January 2021

Counterpoint to 'pneumococcal vaccine after 15 years of use'

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000422.PUB2

7 January 2021

Immunogenicity of the 23-valent pneumococcal polysaccharide vaccine in Alaska Native chronic alcoholics compared with nonalcoholic Native and non-Native controls

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000422.PUB2

7 January 2021

Placebo controlled pneumococcal immunization in patients with bronchogenic carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000422.PUB2

7 January 2021

Precise answers to the wrong question: prospective clinical trials and the meta-analyses of pneumococcal vaccine in elderly and high-risk adults

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000422.PUB2

7 January 2021

Clinical efficacy of pneumococcal vaccine in the elderly: a randomized, single-blind population-based trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000422.PUB2

7 January 2021

Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people. Swedish Pneumococcal Vaccination Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000422.PUB2

7 January 2021

Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in elderly people: a 1-year follow-up

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000422.PUB2

7 January 2021

Incremental effectiveness of pneumococcal vaccine on simultaneously administered influenza vaccine in preventing pneumonia and pneumococcal pneumonia among persons aged 65 years or older

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000422.PUB2

7 January 2021

The additive benefits of influenza and pneumococcal vaccinations during influenza seasons among elderly persons with chronic lung disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000422.PUB2

7 January 2021

Pneumococcal disease after pneumococcal vaccination: an alternative method to estimate the efficacy of pneumococcal vaccine

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000422.PUB2

7 January 2021

Effectiveness of pneumococcal vaccination for elderly people in Catalonia, Spain: a case-control study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000422.PUB2

7 January 2021

Protective Effects of the 23‐Valent Pneumococcal Polysaccharide Vaccine in the Elderly Population: The EVAN‐65 Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000422.PUB2

7 January 2021

Pneumococcal Vaccine in the Institutionalized Elderly: Design of a Nonrandomized Trial and Preliminary Results

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000422.PUB2

7 January 2021

Vaccination against Streptococcus pneumoniae in childhood: lack of demonstrable benefit in young Australian children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000422.PUB2

7 January 2021

No evidence that vaccination with a polysaccharide pneumococcal vaccine protects drug users against all-cause pneumonia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000422.PUB2

7 January 2021

Benefits of pneumococcal vaccination for bedridden patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000422.PUB2

7 January 2021

Pneumococcal vaccine in aboriginal children--a randomized controlled trial involving 60 children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000422.PUB2

7 January 2021

Pneumococcal vaccine efficacy in selected populations in the United States

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000422.PUB2

7 January 2021

The Clinical Effectiveness of Pneumococcal Vaccine in the Elderly

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000422.PUB2

7 January 2021

10.1002/14651858.CD000422.PUB2

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

3094598

OpenCitations bibliographic resource ID

3094598

1 reference